Open AccessmTOR- und Tyrosinkinaseinhibitoren reduzieren AKT- und IGF-R-Expression in Abhängigkeit vom p16-Status von Plattenepithelkarzinomzellen
Author(s) -
B Kuhlin,
Bernhard Kramer,
Nicole Rotter,
Christoph Aderhold
Publication year - 2018
Publication title -
laryngo-, rhino-, otologie
Language(s) - German
Resource type - Conference proceedings
eISSN - 1438-8685
pISSN - 0935-8943
DOI - 10.1055/s-0038-1640074
Subject(s) - erlotinib , gefitinib , protein kinase b , microbiology and biotechnology , chemistry , pi3k/akt/mtor pathway , gynecology , cancer research , medicine , biology , apoptosis , cancer , epidermal growth factor receptor , biochemistry